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EXPERIMENTAL study of the relation of isoniazid to carcinogenesis takes its
origin from human pathology and this is an index of the timeliness ofthe research
and of the seriousness of the problem, which was posed by the Hungarian school
(Berencsi et al., 1952; Juhasz et al., 1957). The root of experimental research
should always be this: experimental pathology not as an end in itself (as is often
the case) but having a starting-point, which is the human disease, and an objective,
which is the solution of the problems inherent in diseases in man (Severi, 1965).
Berencsi et at. (1952) were the first to bring under consideration the enhancing
effect ofisonicotinic acid hydrazide or isoniazid (INH) on the growth ofa neoplasm:
because of a diagnostic error, they administered about 7-7 g. of INH to a 33-year-
old man with a pulmonary tumour, and noted that the clinical course was
extremely rapid owing to precocious, numerous and voluminous metastases.
Pompe showed in 1956 that the cancerous development of Lupus vulgaris
increased after the introduction of INH therapy from 0 5% to 4-6%. Randazzo
(1959), who had already reported a case ofcutaneous tuberculosis treated with INH
which had developed into carcinoma (Randazzo, 1954), makes the point that these
contributions do not permit a possible relationship between this chemical and
cancer to be completely ruled out.
INH and Hydrazine in Mice
Juhasz et al., in 1957, used 95 albino mice about 2 months old; they injected
45 of them intraperitoneally with 1 mg. of INH per day for a period of about 3
months and they kept 50 as controls. In 310% of the treated mice which lived
beyond 71 months, neoplasms of the lungs and the lymph nodes were present,
while the incidence ofneoplasms in the controls was almost insignificant (2%).
Mori and Yasuno (1959) and Mori et al. (1960) reported that this chemical was
carcinogenic for another substrain of mice; they, in fact, obtained pulmonary
tumours in " dd " mice which lived more than 71 months after the start of treat-
ment of 3 to 4 months' duration, with INH added to the diet. The Japanese
workers also observed a relationship between the amount ofdrug and the incidence
of neoplasms, which dropped from 100% to 70%, to 60%, to 50% and to 8%
when the INH dose was cut progressively from 0-25 to 0-125, to 0410, to 0-06 and
to 0-001% of the diet. The subcutaneous administration of INH was equally
effective.
Schwan treated RIII mice with intraperitoneal INH in two experimental
investigations; in the first (1961) he administered 2-50 mg. of INH per day forINH AND CARCINOGENESIS IN ANIMALS
274 days, in the second (1962) 1-25 mg. per day for 87 days. The incidence of
pulmonary tumours was, respectively, 25% and 37%; it was nil in the controls.
Biancifiori and Ribacchi (1962a, b) began their research in this field in 1959:
INH and hydrazine were administered by stomach tube, so that the exact dose
would be known and also so as to use the same route by which these drugs are
normally introduced into human beings (Severi, 1961, 1964a).
It has been shown that in animals INH breaks down into isonicotinic acid and
hydrazine (H2N-NH2) which, in its turn, might be transformed into ammonia
(Porcellati and Preziosi, 1954; Toida, 1962). Hydrazine, therefore, represents
the principal metabolite of INH.
Biancifiori and Ribacchi (1962a, b) administered 2 mg. of INH per day and
equimolecular doses of hydrazine sulphate (1.13 mg.) and sodium salt of isonico-
tinic acid (1.30 mg.), respectively, to three groups of female BALB/c/Cb/Se
substrain mice; the treatment was continued for more than 46 weeks, when all
the mice were killed. In the first two groups, that is, those treated with INH and
hydrazine, all the mice had pulmonary tumours, while in the third group-
treated with sodium salt of isonicotinic acid-lung tumours were present in only
19% of the animals.
The average number of pulmonary tumours per mouse with tumours was 4
after INH, 18 after hydrazine sulphate and 1 after sodium salt of isonicotinic acid.
Histologically they were classified as adenomas (solid and papillary), adenomas
becoming malignant, and carcinomas; their incidence was, respectively, 93,
4 1 and 2.7% ofthe mice treated with INH and 96, 2-2 and 1.7% ofthe mice treated
with hydrazine. The tumours observed in mice treated with sodium salt of
isonicotinic acid were all adenomas.
The results obtained suggested the possibility, as stated above, that the tumours
observed after INH administration to the mouse were due, principally, to the
liberation of hydrazine. In agreement with this pathogenic concept Clayson
(1962) observes that "... if this is confirmed, chemicals which are capable of
liberating hydrazine in the tissues must be regarded as potential carcinogens to
man In order to confirm this possibility, Biancifiori et al. (1963b) treated
BALB/c/Cb/Se and BALB/c/An/Se substrain mice with hydrazine sulphate (1-13
mg. per day). The experiment also had the aim of establishing the induction
time for pulmonary tumours, and studying the resulting morphological changes
with respect to the different survival period after the introduction of an identical
quantity of hydrazine. The induction time ranged around 150 days (after the
200th day the percentage of these pulmonary tumours was not far from 100%0),
the incidence ofthe more malignant forms rose in relation to the quantity ofhydra-
zine administered and with the longer survival time of the mice. With regard to
the previous experiments ofBiancifiori and Ribacchi (1962a, b), in this experiment
the percentage of anaplastic adenomas* and of carcinomas rose, respectively,
from 2.2o% and 1.7o% to 13.47o% and 7.07o%. The greater concentration of these
two neoplastic types occurred in mice which died after the 310th day oftreatment,
when the administration ofhydrazine was discontinued. This shows that, among
the various pulmonary tumours induced in BALB/c/Cb/Se and BALB/c/An/Se
* Anaplastic adenoma: with this term Biancifiori et al. (1963b) included those adenomas that in
other circumstances (Biancifiori and Ribacchi, 1962a, b) they classified as " adenoma becoming
malignant ", and which are characterized principally by undifferentiated elements, some of which
have a certain degree of polymorphism.
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substrain mice by hydrazine, some develop towards malignancy even if the
administration of the carcinogen is interrupted.
Milia (1965) administered hydrazine sulphate by stomach tube to newborn
BALB/c/Cb/Se substrain mice. The treatment lasted 60 days and was subdivided
into 7 periods of 5-10 days each, during which the dose of the chemicals was
increased in relation to the increase in weight of the animals. At the end of the
treatment 17 mg. ofhydrazine sulphate, equal to 4d15 mg. of pure hydrazine, were
administered to each mouse. Ofthe 25 mice treated and killed at about 17 weeks,
24 had pulmonary tumours. The average number of pulmonary tumours per
mouse was 3; the total number of tumours was therefore 72. Histologically,
49 of these (68.05%) were adenomas, 22 (30.55%) adenomas becoming malignant
and 1 (1.3%) a carcinoma.
INH and hydrazine are capable of producing tumours in the lung and in the
lymphatic system in a limited number of types of mice, namely in the " albino ',
" dd ", BALB/c/Cb/Se, BALB/c/An/Se and RIII substrains. Of these, the last
three are known to be susceptible to the induction of such neoplasms by other
chemical carcinogens and it is possible that the first two are also susceptible.
This did not invalidate the results obtained, but it was desirable to see ifINH and
hydrazine were capable of carrying out their carcinogenic action in resistant
strains of mice. Weinstein and Kinosite (1962) treated C57B1 mice, which are
resistant to various carcinogenic factors including those of the lung, orally and
intraperitoneally with even smaller doses of INH. The experiment lasted about
32 weeks and tumours were induced in the lung.
With the same aim in view Biancifiori et al. (1963a, 1964a) administered INH
and hydrazine to CBA/Cb/Se mice of both sexes for 36 weeks. CBA mice are
well known for their low susceptibility to pulmonary carcinogens. In Orr's
experiment (1947) it proved the most resistant to the induction of pulmonary
tumours among six substrains tested in this way by means of intranasal intro-
duction of methylcholanthrene. Biancifiori et al. (1963a, 1964a) showed that,
in mice of this substrain surviving 38-110 weeks, INH (2 mg. per day) and hydra-
zine sulphate (1.13 mg. per day), administered for 36 weeks, induced pulmonary
tumours in 610% and 76% respectively of males and in 76% and 90% respectively
of females. In the group treated with INH, the average number of pulmonary
tumours per mouse was 2 in the males and 3 in the females; in that treated with
hydrazine it was, respectively, 3 and 6. The tumours were classified histologically
as: adenomas, anaplastic adenomas and carcinomas; their incidence was, respec-
tively, 87.5%, 0% and 12-5% in male mice and 67.6%, 21.2% and 10.8% in
female mice treated with INH. In mice subjected to the action of hydrazine,
for males and females the adenomas were, respectively, 77.8% and 76-7%, the
anaplastic adenomas were 9-5% and 16.4% and the carcinomas 13.0% and 4 9%.
In all the CBA/Cb/Se substrain mice in this experiment, the majority of the
anaplastic adenomas and carcinomas were found in the animals surviving the
longest, when the treatment had been discontinued for several weeks. In this
respect, therefore, this substrain ofmice behaved in relation to INH and hydrazine
like the BALB/c/Cb/Se andBALB/c/An/Se substrains, with and without mammary
tumour virus (MTV) (Biancifiori et al., 1963b; Ribacchi et al., 1963).
This progression towards malignancy in pulmonary tumours induced by INH
and hydrazine contrasts with Cowen's observations (1947) in C57B1 mice treated
with urethane. It would seem, in fact, that pulmonary tumours induced byINH AND CARCINOGENESIS IN ANIMALS
urethane in these mice had the tendency to regress after the treatment was discon-
tinued. This has been attributed to the low incidence of spontaneous pulmonary
tumours in the C57B1 substrain. The CBA/Cb/Se substrain also has a low
spontaneous incidence of these neoplasms (Biancifiori et al., 1963a) but in these
mice, along with a considerable increase in the percentage of pulmonary tumours,
the progression of these towards malignancy in mice surviving after the 36th week
oflife has also been noted (Biancifiori et al., 1963a), that is, after the treatment had
been interrupted. This might give rise to the idea that the carcinogenic potential
of INH and hydrazine in these mice is greater than that of urethane. This
hypothesis is confirmed also by observations concerning the morphological and
biological characteristics ofpulmonary tumours induced in CBA mice by urethane.
Nettleship et al. (1943), in fact, reported that these tumours showed no evidence
of invasion and did not metastasize. In CBA/Cb/Se substrain mice treated by
Biancifiori et al. (1963a), however, 4 pulmonary carcinomas metastasized, one (in a
female treated with INH) to the kidneys and three (in females treated with
hydrazine) to the paratracheal lymph nodes. In several treated mice adrenal
alterations, characterized by hyperplasia and brown degeneration, were also found.
Moreover, the interest in this research lies in the fact that hydrazine sulphate
induced hepatomas as well, in 620% of the males and in 710% of the females still
alive from 20 to 99 weeks after the start of the treatment (Biancifiori et al., 1964a;
Severi, 1964b). The spontaneous incidence of these tumours is 110% in males and
4% in females in the CBA/Cb/Se substrain. Many hepatomas obtained in the
mice treated with hydrazine were solid but others contained wide vascular spaces,
threaded through with endothelial cells, which often penetrated the peritoneum.
Four hepatomas in males and 2 in females metastasized in the lungs.
When it was shown that it was possible to induce pulmonary tumours in
BALB/c/Cb/Se and CBA/Cb/Se substrain mice both with INH and hydrazine,
and hepatomas in CBA/Cb/Se substrain mice with hydrazine, it was also considered
of interest to try to induce skin tumours with croton oil after " initiation " with
one or the other compound. For this investigation BALB/c/Cb/Se substrain
mice 8 weeks old were used, the treatment being oral administration ofINH (2 mg.
per day) or hydrazine (1.13 mg. per day) for 4 weeks, followed by painting with
croton oil twice a week for 30 weeks. Skin tumours were not obtained; however,
even with such limited doses of INH and hydrazine the incidence of pulmonary
tumours rose from approximately 270% in the controls to about 800% in the treated
mice still alive from 38 to 99 weeks after the start of the treatment. The average
number of pulmonary tumours per mouse was 1-7 in the group treated with INH
and 2-9 in that treated with hydrazine. The majority of the neoplasms was
represented by adenomas, some of them becoming malignant (or anaplastic).
Metastases were not found.
Biancifiori and Ribacchi (1962a, b) did not observe spontaneous pulmonary
tumours in female BALB/c breeding mice, the majority of which died before the
79th week. When, however, BALB/c/Cb/Se virgin mice were kept in conditions
identical with those of the treated mice, 27% of the females and 210% of the males
developed spontaneous pulmonary tumours. Ofthese, 2 tumours appeared before
79 weeks. the other 9 between 80 and 99 weeks (Biancifiori et al., 1964a). It may
be concluded, therefore, that this substrain has a low incidence of spontaneous
pulmonary tumours in aged mice, and that for an adequate control on the experi-
mental mice, survival must be equal in the two groups.
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Siegel and Iwainsky (1960a) reported that the administration of INH to mice
into which Ehrlich's ascites tumour was introduced intravenously lessened the
metastasizing of it in the various organs. The same authors (1960a, b) and Siegel
(1962) showed that if the drug is administered after the transplantation of the
tumour, it grows regularly; if, on the other hand, INH precedes the transplanta-
tion, the neoplastic development is inhibited.
Biancifiori et al. (1966) studied the histogenesis ofpulmonary tumours induced
with hydrazine sulphate in BALB/c/Cb/Se mice. From the results obtained, they
state that in mice of this substrain, after the treatment with hydrazine sulphate,
the majority of tumours originate in the alveoli. This observation cannot be
generalized, however, since it may be that other carcinogens, in this or in other
substrains of mice, stimulate the bronchial epithelium carcinogenically more than
the alveolar epithelium.
Hydrazine Derivatives in Mice
Milia et al. (1964) administered 4-(isonicotinylhydrazone) pimelic acid (4-INIP),
2 mg. per day up to a total dose of 300 mg., to BALB/c/Cb/Se substrain mice.
This chemical induced pulmonary tumours in 70.2% and leukaemia in 29.4% of
mice still alive between 30 and 89 weeks. The average number of pulmonary
tumours per mouse was 1-73 and, histologically, 86% were adenomas, 8% ana-
plastic adenomas and 6% carcinomas. Of the carcinomas, one metastasized in a
tracheo-bronchial lymph node. This carcinoma was of a peculiar appearance in
that it was characterized by noticeable vascularity. Hyperplasia and brown
degeneration of the adrenals were also observed in mice treated with 4-INIP.
In the lungs of mice with tumours groupings of cubic cells with badly-defined
walls were frequently noted in relation to the terminal bronchiolus or forming a
continuous endoalveolar stratum. These findings were similar to those observed
in CBA/Cb/Se substrain mice treated with INH and hydrazine and which were
classified as " initial adenomatous aspects " (Biancifiori et al., 1963a). Almost
identical histological patterns have been described by other research workers in the
lungs ofmice treated both with urethane and with INH, and defined as ". . . earliest
stages of tumour formation " (Selbie and Thackray, 1948), " earliest lesions "
(Nettleship et al., 1943), " foci of increased cellularity " (Mostofi and Larsen, 1957)
and " hypercellularity areas " (Mori and Yasuno, 1959).
According to Milia et al. (1964) the myeloid leukaemias observed in mice
treated with 4-INIP are to be attributed to the relative stability of the hydrazinic
group in this chemical, because of which hydrazine would be liberated less readily
than from INH and, therefore, this metabolite would be able to carry out its action
in cellular regions other than in the lung, for example in the reticulo-endothelial
system. Juhasz et al. (1963), however, had already obtained tumours of the lymph
nodes and leukaemias in " albino " mice by the intraperitoneal administration of
INH. A reticulum sarcoma localized in the retroperitoneal lymph node and
progressed into an ascitic form which was transplantable (Kendrei and Cossel,
1963). An INH induced pulmonary tumour in a male BALB/c/ substrain mouse
(Ribacchi et al., 1963) was transplanted and is at present in the 20th generation of
homotransplantation.
Clayson et al. (1966) studied the carcinogenic action for the lung in BALB/c/Cb/
Se substrain mice of the following hydrazine derivatives: benzoyl hydrazide,
2-methoxybenzoyl hydrazide, 4-methoxybenzoyl hydrazide, phenylhydrazide
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hydrochloride and iproniazid. The first three derivatives raised the percentage
ofmice with pulmonary tumours and the number ofpulmonary tumours per mouse
above the levels found in untreated animals of the same age. Phenylhydrazide
hydrochloride did not increase either the incidence of pulmonary tumours or the
number of pulmonary tumours per mouse to the same extent as the first three
derivatives, but the malignancy of the tumours produced was more marked.
Iproniazid showed no significant carcinogenic action. Histologically the tumours
were not much different from those induced by INH and hydrazine, except for a
high degree of vascularity. This peculiarity had already been noted in the hepa-
tomas produced by hydrazine sulphate in CBA/Cb/Se substrain mice (Biancifiori
et al., 1964a).
Kelly et al. (1964) administered a hydrazine derivative, N-isopropyl-alfa-
(2-methylhydrazino)-p-toluamide hydrochloride (MIH), orally and intraperitone-
ally, to CD2F1 strain mice, and within 15 weeks pulmonary tumours were found in
100% and leukaemias in 50% of the treated mice.
INH, Hydrazine and MIH in Rats
Kelly et al. (1964) administered, orally and intraperitoneally, a hydrazine
derivative, N-isopropyl-alfa-(2-methylhydrazino)-p-toluamide hydrochloride
(MIH), to Osborne-Mendel rats of both sexes; within 16 weeks mammary carci-
nomas developed in all the female rats and in 18% of the males.
Biancifiori et al. (unpublished data) treated 32 C.B.R.I. rats* (14 males and
18 females) from the age of 8 weeks with hydrazine sulphate administered by
stomach tube for a period ofabout 68 weeks. The total number ofadministrations
was 215 because the treatment was interrupted by adequate rest periods. The
daily dose was 18 mg. for males and 12 mg. for females, so that the average amount
of chemical administered to each animal was, respectively, 3870 and 2580 mg.
At natural death, 8 rats (25%; 3 males and 5 females) had pulmonary tumours;
age: mean 77, range 71 to 89 weeks. One rat, which died at 76 weeks, had a
voluminous tumour that occupied the complete left lung (Fig. 1).
Histological examination showed that the tumours were adenocarcinomas
(Fig. 2), anaplastic carcinomas (Fig. 3) and combined squamous and adeno-
carcinomas (Fig. 4, 5).
No lung tumours were found in 50 control rats of both sexes which were killed
at an average age of about 91 weeks.
Wagner and Moritz (1962) noted that small doses of INH favour the growth
of various transplanted tumours in the rat, whereas larger doses inhibit it.
INH in Rabbits
Tiboldi et al. (1955) investigated the influence of INH on the growth of the
Brown-Pearce tumour in the rabbit. The drug was administered by stomach
tube in a dose of 10 mg./kg. per day and it appeared to favour the formation,
number and dimensions of the metastases, while it did not influence the mitoses.
Pansa and Bikfalvi (1960) studied the effect produced by INH applied directly
on the tracheo-bronchial mucosa of the rabbit and observed papilloma-type
lesions. These findings, which agree with the papillomatous patterns reported
* Albino rats supplied in 1954 by the Chester Beatty Research Institute, London, and kept
" at random " in the Division of Cancer Research, Perugia.
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by others (De Figueiredo and De Paola, 1955) in the bronchial epithelium of
tubercular patients treated with INH, have not been confirmed (Viallier and
Casanova, 1960).
The Question of the Chemical Group Responsible
As far as identifying the chemical group responsible for the pulmonary tumours
which INH is capable ofinducing in mice is concerned, three possibilities have been
put forward.
According to Mori et al. (1960) and Juhasz et al. (1957) it should prove to be the
carbamyl group
0
11
(NH2-C-R)
They base their contention principally on the fact that the carbamyl group is
present in other pulmonary carcinogens as well as in urethane and pyrazinamide.
Biancifiori et al. (1963a, b) believe that hydrazine (H2N-NH2) is responsible
and point out that hydrazine, when administered alone, has shown clear carcino-
genic properties for the lungs.
The importance of hydrazine was confirmed by another experiment in which
Biancifiori et al. (1964b) administered ethionamide to BALB/c/Cb/Se substrain
mice. This chemical is derived, like INH, from isonicotinic acid but, unlike INH,
it does not contain the hydrazine group. Its oral administration, carried out for
about 50 weeks broken by rest periods so that the effective number of treatments
was 300 and the total dose 600 mg., did not produce tumours of the lung.
F. L. Rose (personal communication) suggested that the mode of action of
hydrazine might be through the intermediate formation in vivo of hydrazones,
which might then become oxidized, as is possible in vitro, to diazonium derivatives:
R.CHO +NH2NH2 -R.CH N.NH2 -R.CHN2
In this way, formaldehyde, either by itself or as a functional derivative such
as hydroxymethylfolinic acid, could lead to the formation of diazomethane. A
related mechanism is probably concerned in carcinogenesis by dimethylnitro-
samine (Magee, 1963).
If this suggestion is correct, it is necessary to postulate that methylhydrazine,
which is not carcinogenic (Kelly etal., 1964), cannot be oxidized to this methylating
agent and that the non-carcinogenic iproniazid (Clayson et al., 1966) similarly does
not form an alkylating agent in the body. Isoniazid may either be hydrolysed in
EXPLANATION OF PLATES
FIG. 1.-Male rat 76 weeks old. Hydrazine sulphate 3870 mg. (1) Trachea. (2) A large
growth replacing the left lung. (3) Diaphragm. (4) Intestines. (5) Heart. (6) Right
lung. (7) Liver.
FIG. 2. Adenocarcinoma of the left lung. Female rat 75 weeks old. Hydrazine sulphate
2580mg. H. & E. x45.
FIG. 3.- Anaplastic carcinoma of the left lung with invasion of the blood vessels; on the
left, lung tissue with oedema. Male rat 76 weeks old. Hydrazine sulphate 3870 mg. PAS.
x45.
FIG. 4. Combined squamous and adenocarcinoma (cf. left lung Fig. 1); here, adenocarcinoma-
tous growth. Male rat 76 weeks old. Hydrazine sulphate 3870 mg. H. & E. x 58.
FIG. 5. Combined squamous and adenocarcinoma (cf. Fig. 1 and 4); here, squamous growth.
Male rat 76 weeks old. Hydrazine sulphate 3870 mg. H. & E. x 58.
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the animal body to hydrazine or may interact directly with formaldehyde, in
which case hydrolysis and oxidation to the methylating agent will follow:
CO. NH. NH2 CO. NH. NH. CH20H CO. OH
+CH2N2
INH and Malignant Tumours in Human Beings
Apart from the question as to the extent to which experiments on animals are
relevant to carcinogenesis in man, it is possible to say that, to date, there is little
direct evidence to support the carcinogenicity of INH in man. Not all patients,
however, who have been treated with INH, with or without tuberculosis, have been
autopsied. In addition, tuberculosis that has not been treated with INH no
longer exists for practical purposes, so that a comparative evaluation would be
impossible. A further point is that we do not know what the induction time is for
cancer of the lung by INH (Roe et al., 1965).
It is very strange that there is frequent discussion of the dangers that certain
drugs, antiseptics, dyes, flavouring agents, bacteria, bacterial products, chemical
additives and pesticides represent for the development of cancer and that there is
this sort of conspiracy of silence, not really broken by two letters to the editor
and an editorial in two summer issues of the British Medical Journal, 1965, on the
carcinogenic potentiality of INH, which is being used more and more indis-
criminately, even in children (Roe et al., 1965; Clayson, 1965).
We must not at this stage give up, without further evidence, the use of such a
highly potent drug in the treatment of tuberculosis in adults, but the problem of
the carcinogenic potentiality of INH for man has to be faced. It should perhaps
be borne in mind also that the same chemical can affect different tissues in different
species. There is no certainty that even if INH induces tumours in man these
will be leukaemias or carcinomas ofthe lung and liver as in mice and rats (Clayson,
1965).
The carcinogenic action of INH in rats and in mice, and the effectiveness of
INH in tuberculosis should lead to (a) research on another drug for the treatment
oftuberculosis which will be as effective as INH but not a potential carcinogen for
man; (b) informing users ofthis drug that its administration constitutes a potential
carcinogenic hazard; (c) withholding INH from children in all circumstances.
CONCLUSIONS
Experimental pathology has shown that INH and some of its allied compounds
can induce tumours in the lung, the liver and the lymph glands in the mouse, and
in the lung and breast in rats. The problem of the carcinogenic action of these
drugs, some of them widely used in man, has scarcely been touched on, and a
great deal of time will be needed to establish whether or not there are implications
for human pathology.
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For the moment we consider it appropriate to associate ourselves with those
who wonder: "... is the experimental induction of alveologenic carcinoma by
carcinogenic agents a meaningful index of the aetiologic significance of these
agents in the pathogenesis of lung cancer in man? " (Kotin and Wisely, 1963).
Before concluding we should like to draw attention to the frequent observation
that in mice treated with INH and hydrazine (Biancifiori et al., 1963a) and with
4-INIP (Milia et al., 1964), in addition to lung tumours, brown degeneration and
hyperplasia of the adrenals were present. Taking into consideration the adrenal
modifications observed in the subjects affected with lung cancer (Nichols and
Gourley, 1963; Williams and Sommers, 1962) the increased excretion of 17-keto-
steroids in patients subjected to INH therapy (Krulik and Kohout, 1963) and
epithelial broncho-alveolar proliferation in man and in the rabbit after treatment
with corticosteroids (Berkheiser, 1963), the existence of a relationship between the
cortico-adrenal glands and lung cancer is possible.
SUMMARY
Isoniazid (INH) can induce tumours of the lung in " albino ", "dd ", RIII,
BALB/c/Cb/Se, C57B1, CBA/Cb/Se mice; in rabbits it enhances the development
of the Brown-Pearce tumour and papillomas of the tracheo-bronchial mucosa.
It has a growth-inhibiting property in transplanted tumours in rats and reduces
metastasizing of Ehrlich's tumour in mice; depending on the time of administra-
tion, it influences the take and development of transplanted tumours in mice.
Hydrazine (a hydrolysis product of INH) can induce tumours of the lung in
BALB/c/Cb/Se, BALB/c/An/Se, CBA/Cb/Se mice and in Cb London rats. It
induces tumours of the liver in CBA/Cb/Se mice.
Hydrazine derivatives: 4-(isonicotinylhydrazone) pimelic acid (4-INIP) can
induce tumours of the lung and leukaemias in BALB/c/Cb/Se mice: benzoyl
hydrazide, 2-methoxybenzoylhydrazide, 4-methoxybenzoyl hydrazide andpossibly
phenylhydrazine hydrochloride can induce tumours of the lung in BALB/c/Cb/Se
mice; N-isopropyl-alfa-(2-methylhydrazine)-p-toluamide hydrochloride (MIH)
can induce tumours ofthe lung and leukaemias in CD2F1 mice, and tumours ofthe
mammary gland in Osborne Mendel rats.
Some believe that the carbamyl group
0
11
(NH2-C-R)
in INH is responsible for the tumours while others (among them the Perugia
workers) favour hydrazine (H2N-NH2).
These and other facts suggest that isoniazid and some of its allied compounds
may be important in the development of lung tumours in human beings. It is
possible that the origin oflung tumours may involve the hormones of the adrenal
cortex.
The authors are very much indebted to Dr. P. R. Peacock, Glasgow, and Dr.
D. B. Clayson, Leeds, for their valuable comments on this paper.
This work was supported in part by grants from the Anna Fuller Fund, New
Haven, Connecticut, and the Council for Tobacco Research, U.S.A., New York,
U.S.A.
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